• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

GSK4112

CAS No. 1216744-19-2

GSK4112 ( SR6452;GSK-4112;GSK 4112;SR-6452;SR 6452 )

产品货号. M10812 CAS No. 1216744-19-2

A potent and selective small molecule Rev-erbα agonist with EC50 of 0.4 uM in biochemical assay.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥348 有现货
10MG ¥624 有现货
25MG ¥1320 有现货
50MG ¥2398 有现货
100MG ¥4301 有现货
200MG 获取报价 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    GSK4112
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    A potent and selective small molecule Rev-erbα agonist with EC50 of 0.4 uM in biochemical assay.
  • 产品描述
    A potent and selective small molecule Rev-erbα agonist with EC50 of 0.4 uM in biochemical assay; mediates the repression of Rev-erbα target gene bmal1 in liver cells, and inhibits and shifts the phase of gluconeogenesis in primary mouse hepatocytes.
  • 同义词
    SR6452;GSK-4112;GSK 4112;SR-6452;SR 6452
  • 通路
    Autophagy
  • 靶点
    Autophagy
  • 受体
    Rev-ErbBα
  • 研究领域
    Metabolic Disease
  • 适应症
    ——

化学信息

  • CAS Number
    1216744-19-2
  • 分子量
    396.89
  • 分子式
    C18H21ClN2O4S
  • 纯度
    >98% (HPLC)
  • 溶解度
    10 mM in DMSO
  • SMILES
    O=C(OC(C)(C)C)CN(CC1=CC=C(Cl)C=C1)CC2=CC=C([N+]([O-])=O)S2
  • 化学全称
    Glycine, N-[(4-chlorophenyl)methyl]-N-[(5-nitro-2-thienyl)methyl]-, 1,1-dimethylethyl ester

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Grant D, et al. ACS Chem Biol. 2010 Oct 15;5(10):925-32.
2. Trump RP, et al. J Med Chem. 2013 Jun 13;56(11):4729-37.
3. Chandra V, et al. Autophagy. 2015 Nov 2;11(11):1987-1997.
产品手册
关联产品
  • Dilmapimod

    Dilmapimod is a potent inhibitor of p38 MAPK ,it potentially suppresses inflammation in chronic obstructive pulmonary disease.

  • UVI 3003

    UVI 3003 is a highly selective antagonist of the retinoid X receptor. UVI 3003 inhibits Xenopus and human RXRα in Cos7 cells (IC50s: 0.22 and 0.24 μM, respectively).

  • DMXAA

    A vascular disrupting agent (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 uM; activates STING dependent innate immune pathways.